I come with 17+ years of international biotech, medtech and life science industry experience enabling stakeholders to assess market opportunities based on robust and in-depth analysis of target market and competitive environment. I have had multiple years of experience in strategic management consulting wherein I have evaluated several early stage assets for the global pharma/biotech and medtech industry.
At Oivi, I lead commercial strategy where I contribute to aspects of business development, business
design and product commercialization. I am directly responsible for leading the business development team to drive market penetration and commercial adoption. A key aspect of my role at Oivi is to support
identification and evaluation of organic and inorganic business opportunities that could impact growth and profitability. In addition to spearheading go-to-market strategies, I work alongside the leadership team to develop people and drive performance.
I also serve as a partner at Ventac Partners, a management consulting firm where I head market intelligence and advise early stage biotech and pharma companies on market evaluations and commercialization strategy.
Prior to joining Oivi, Ventac Partners, I conceptualized and established the successful start-up StrataPRO – a global healthcare consulting company, with expertise in the areas of Commercial Analytics, Market Intelligence and Market Research Consulting.
I hold a Master’s in Business Administration (MBA) with specialization in Marketing from Ohio University, USA. In addition, she holds a M.S. degree in Biomedical Sciences from Kingston University, UK and a Bachelor’s degree in Microbiology from India.
Day 1 - 17 October 2022
| Time |
Session |
|
|
14:00
16:00
|
The R&D to commercialisation route for digital health solutions are very challenging. How do aspiring Nordic innovators and researchers minimise risks to ensure higher chances of commercial success? A Case-Sharing session by the Nordic Companies on their journey to success
|
